SRGN and head and neck squamous cell carcinoma: Similar results have been found in different tumors, as described by Xie et al. [27], they claimed that CAFs secrete hypoxia-induced serglycin to facilitate head and neck squamous cell carcinoma tumor cells growth through the Wnt/β–catenin pathway activated.